Boussard & Gavaudan Investment Management LLP - TRAVERE THERAPEUTICS INC ownership

TRAVERE THERAPEUTICS INC's ticker is and the CUSIP is 89422GAA5. A total of 23 filers reported holding TRAVERE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Boussard & Gavaudan Investment Management LLP ownership history of TRAVERE THERAPEUTICS INC
ValueSharesWeighting
Q4 2022$3,469,543
-13.5%
3,8000.0%0.38%
-32.5%
Q3 2022$4,011,0003,8000.57%
Other shareholders
TRAVERE THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Context Capital Management, LLC 29,167$23,4612.12%
BRAIDWELL LP 28,350,000$22,804,0310.74%
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) 25,000,000$20,400,8860.64%
READYSTATE ASSET MANAGEMENT LP 9,000,000$7,239,3750.54%
WOLVERINE ASSET MANAGEMENT LLC 45,400,000$36,908,5130.44%
Segantii Capital Management Ltd 8,000,000$6,566,9600.34%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 7,000,000$5,700,5200.25%
CAPSTONE INVESTMENT ADVISORS, LLC 44,393,000$35,708,6190.18%
LINDEN ADVISORS LP 13,993,000$11,365,8140.12%
AVIVA PLC 18,000,000$14,728,9500.06%
View complete list of TRAVERE THERAPEUTICS INC shareholders